三氮唑并噻二唑类DOT1L抑制剂的结构修饰及活性

Translated title of the contribution: Structural Modifications of the Triazolo-thiadiazole Derivatives as DOT1L Inhibitors and Their Activities
  • Xiaoming Xu
  • , Siqi Guo
  • , Jing Zhang
  • , Yantao Chen
  • , Yaqing Kang
  • , Na Liu
  • , Junfang Liu
  • , Cheng Luo
  • , Shijie Chen*
  • , Hua Chen*
  • *Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

A series of novel derivatives containing triazolo-thiadiazole moiety have been synthesized by structural modifications on a lead disruptor of telomeric silencing 1-like (DOT1L) inhibitor 8. All the compounds have been evaluated for their DOT1L inhibitory activities at the concentration of 50 μmol/L. The results showed that the tested compounds showed certain DOT1L inhibitory activities. Among them, N, N-dimethyl-4-(6-methyl-[1, 2, 4]triazolo[3, 4-b] [1, 3, 4]thiadiazol-3-yl)aniline (14b) and (R)-tert-butyl (1-((3-(4-(dimethylamino)phenyl)-[1, 2, 4]triazolo[3, 4-b] [1, 3, 4]thiadiazol-6-yl)methyl)-piperidin-3-yl)carba- mate (16a) were the best ones with IC50 values of 7.37 and 7.84 μmol/L, respectively, near that of the positive control 8. The structure-activity analysis showed that when the triazolo-thiadiazole moiety occupied the binding-site of S-adenosylmethionine (SAM) in DOT1L and R1 group was 4-N, N-dimethyl, the hydrophobic substituents as the tailed R2 groups would be accommodated into the DOT1L binding site, and the sizes of the substituents seemed no effects on their DOT1L inhibitory activities of the compounds.

Translated title of the contributionStructural Modifications of the Triazolo-thiadiazole Derivatives as DOT1L Inhibitors and Their Activities
Original languageChinese (Traditional)
Pages (from-to)1345-1354
Number of pages10
JournalChinese Journal of Organic Chemistry
Volume40
Issue number5
DOIs
StatePublished - 1 May 2020
Externally publishedYes

Fingerprint

Dive into the research topics of 'Structural Modifications of the Triazolo-thiadiazole Derivatives as DOT1L Inhibitors and Their Activities'. Together they form a unique fingerprint.

Cite this